Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emblem Corp EMMBF

Healthcare Biotechnology Cannabis
"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."


OTCPK:EMMBF - Post by User

Emblem Corp > Investor Relations On Twitter
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by GrahamCrackeron Apr 09, 2018 3:29pm
72 Views
Post# 27854862

RE:Investor Relations On Twitter

RE:Investor Relations On Twitter Could be related to this, from the CEO's announcement to shareholders:

"We are also making improvements to our existing “closed-box” cultivation facility, with retro-fits to three grow rooms nearly complete in order to provide greater environmental control for our production team. In addition, we are assessing GMP certification for the facility, which would allow us to internationally export dried flower in addition to derivative products.  International expansion is a key focus for Emblem’s growth strategy, and we have signed an LOI with a German pharmacy group to supply dried flower to Germany and the EU, subject to GMP compliance."
Read more at https://www.stockhouse.com/news/press-releases/2018/03/20/emblem-corp-issues-presidents-letter-to-shareholders#cLOsxWkhfsFADwSe.99
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities